<DOC>
	<DOC>NCT02156323</DOC>
	<brief_summary>This single center, open-label, randomized study will investigate the drug-drug interaction potential between multiple doses of RO7033877 and multiple doses of colistin methanesulfonate sodium (CMS).</brief_summary>
	<brief_title>A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)</brief_title>
	<detailed_description />
	<mesh_term>Colistin</mesh_term>
	<criteria>Adult male or female (of non childbearing potential) healthy volunteers between 18 to 55 years Body mass index (BMI) between 18 and 30 kg/m2 Non smokers Use adequate contraception methods Evidence of active of chronic disease Regular consumption of drugs of abuse Infection with human immunodeficiency virus (HIV), hepatitis B (HBV) or hepatitis C (HCV) History of significant allergic reactions Abnormal blood pressure Clinically significant abnormalities (e.g. cardiovascular, laboratory values)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>